ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 95 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,136 | -83.0% | 4,357 | -69.5% | 0.01% | -78.3% |
Q2 2023 | $136,155 | -96.1% | 14,287 | -95.5% | 0.02% | -96.6% |
Q1 2023 | $3,488,672 | +15.6% | 317,152 | +55.6% | 0.67% | +14.9% |
Q4 2022 | $3,017,010 | -28.6% | 203,852 | -7.8% | 0.58% | -29.8% |
Q3 2022 | $4,223,000 | +10.1% | 220,985 | +22.8% | 0.83% | +7.6% |
Q2 2022 | $3,836,000 | -9.1% | 180,016 | -17.9% | 0.77% | +3.2% |
Q1 2022 | $4,221,000 | -16.5% | 219,136 | -10.1% | 0.75% | -1.6% |
Q4 2021 | $5,055,000 | -72.1% | 243,736 | -67.9% | 0.76% | -49.5% |
Q3 2021 | $18,127,000 | -12.5% | 758,763 | 0.0% | 1.51% | -10.0% |
Q2 2021 | $20,707,000 | -18.6% | 758,763 | -13.7% | 1.68% | -13.1% |
Q1 2021 | $25,428,000 | – | 878,948 | – | 1.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 10,542,790 | $314,175,000 | 35.62% |
Bain Capital Life Sciences Investors, LLC | 3,979,292 | $118,583,000 | 20.06% |
Omega Fund Management, LLC | 844,680 | $25,171,000 | 10.42% |
Vivo Capital, LLC | 1,686,527 | $50,259,000 | 4.55% |
Orbimed Advisors | 4,673,850 | $139,281,000 | 2.34% |
RA Capital Management | 1,165,184 | $34,722,000 | 1.10% |
Polar Capital LLP | 375,000 | $11,175,000 | 0.12% |
CAAS CAPITAL MANAGEMENT LP | 22,413 | $668,000 | 0.07% |
FMR LLC | 5,713,343 | $170,258,000 | 0.02% |
Laurion Capital Management LP | 50,000 | $1,490,000 | 0.02% |